209 related articles for article (PubMed ID: 24335142)
21. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
22. Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation.
Runfola V; Sebastian S; Dilworth FJ; Gabellini D
J Cell Sci; 2015 Feb; 128(4):631-7. PubMed ID: 25609712
[TBL] [Abstract][Full Text] [Related]
23. Identification of recurrent regulated alternative splicing events across human solid tumors.
Danan-Gotthold M; Golan-Gerstl R; Eisenberg E; Meir K; Karni R; Levanon EY
Nucleic Acids Res; 2015 May; 43(10):5130-44. PubMed ID: 25908786
[TBL] [Abstract][Full Text] [Related]
24. Death by splicing: tumor suppressor RBM5 freezes splice-site pairing.
Kotlajich MV; Hertel KJ
Mol Cell; 2008 Oct; 32(2):162-4. PubMed ID: 18951082
[TBL] [Abstract][Full Text] [Related]
25. The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of
Bernard A; Hibos C; Richard C; Viltard E; Chevrier S; Lemoine S; Melin J; Humblin E; Mary R; Accogli T; Chalmin F; Bruchard M; Peixoto P; Hervouet E; Apetoh L; Ghiringhelli F; Végran F; Boidot R
Cancer Immunol Res; 2021 Mar; 9(3):324-336. PubMed ID: 33419764
[TBL] [Abstract][Full Text] [Related]
26. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
[TBL] [Abstract][Full Text] [Related]
27. Histone and RNA-binding protein interaction creates crosstalk network for regulation of alternative splicing.
Kim YE; Park C; Kim KE; Kim KK
Biochem Biophys Res Commun; 2018 Apr; 499(1):30-36. PubMed ID: 29551686
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated regulation of alternative splicing.
Venables JP; Klinck R; Koh C; Gervais-Bird J; Bramard A; Inkel L; Durand M; Couture S; Froehlich U; Lapointe E; Lucier JF; Thibault P; Rancourt C; Tremblay K; Prinos P; Chabot B; Elela SA
Nat Struct Mol Biol; 2009 Jun; 16(6):670-6. PubMed ID: 19448617
[TBL] [Abstract][Full Text] [Related]
30. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing induces cytoplasmic localization of RBFOX2 protein in calcific tendinopathy.
Cho N; Kim JO; Lee S; Choi S; Kim J; Ko MS; Park SJ; Ji JH; Kim KK
Exp Mol Pathol; 2019 Aug; 109():36-41. PubMed ID: 31128090
[TBL] [Abstract][Full Text] [Related]
32. PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.
Ray P; Kar A; Fushimi K; Havlioglu N; Chen X; Wu JY
J Mol Neurosci; 2011 Nov; 45(3):453-66. PubMed ID: 21881826
[TBL] [Abstract][Full Text] [Related]
33. Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors.
Bordeleau F; Califano JP; Negrón Abril YL; Mason BN; LaValley DJ; Shin SJ; Weiss RS; Reinhart-King CA
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8314-9. PubMed ID: 26106154
[TBL] [Abstract][Full Text] [Related]
34. It's a bit over, is that ok? The subtle surplus from tandem alternative splicing.
Szafranski K; Kramer M
RNA Biol; 2015; 12(2):115-22. PubMed ID: 25826565
[TBL] [Abstract][Full Text] [Related]
35. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
[TBL] [Abstract][Full Text] [Related]
36. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
Terenzi F; Ladd AN
RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression.
Hirschfeld M; Zhang B; Jaeger M; Stamm S; Erbes T; Mayer S; Tong X; Stickeler E
Mol Carcinog; 2014 Nov; 53(11):883-92. PubMed ID: 23765422
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion.
Liu Y; Conaway L; Rutherford Bethard J; Al-Ayoubi AM; Thompson Bradley A; Zheng H; Weed SA; Eblen ST
Nucleic Acids Res; 2013 May; 41(9):4949-62. PubMed ID: 23519612
[TBL] [Abstract][Full Text] [Related]
39. NeuN/Rbfox3 nuclear and cytoplasmic isoforms differentially regulate alternative splicing and nonsense-mediated decay of Rbfox2.
Dredge BK; Jensen KB
PLoS One; 2011; 6(6):e21585. PubMed ID: 21747913
[TBL] [Abstract][Full Text] [Related]
40. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
